- Home
- DOMO vs ABSI Comparison
DOMO vs ABSI Comparison
Compare DOMO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- ABSI
- Stock Information
- Founded
- DOMO 2010
- ABSI 2011
- Country
- DOMO United States
- ABSI United States
- Employees
- DOMO N/A
- ABSI N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- ABSI Health Care
- Exchange
- DOMO Nasdaq
- ABSI Nasdaq
- Market Cap
- DOMO 436.2M
- ABSI 353.8M
- IPO Year
- DOMO 2018
- ABSI 2021
- Fundamental
- Price
- DOMO $12.70
- ABSI $2.65
- Analyst Decision
- DOMO Hold
- ABSI Strong Buy
- Analyst Count
- DOMO 6
- ABSI 5
- Target Price
- DOMO $10.67
- ABSI $8.40
- AVG Volume (30 Days)
- DOMO 723.4K
- ABSI 2.9M
- Earning Date
- DOMO 05-21-2025
- ABSI 05-13-2025
- Dividend Yield
- DOMO N/A
- ABSI N/A
- EPS Growth
- DOMO N/A
- ABSI N/A
- EPS
- DOMO N/A
- ABSI N/A
- Revenue
- DOMO $317,052,000.00
- ABSI $4,815,000.00
- Revenue This Year
- DOMO $0.86
- ABSI $145.79
- Revenue Next Year
- DOMO $1.58
- ABSI $99.29
- P/E Ratio
- DOMO N/A
- ABSI N/A
- Revenue Growth
- DOMO N/A
- ABSI N/A
- 52 Week Low
- DOMO $6.01
- ABSI $2.01
- 52 Week High
- DOMO $13.28
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- DOMO 81.47
- ABSI 40.44
- Support Level
- DOMO $8.40
- ABSI $2.56
- Resistance Level
- DOMO $13.28
- ABSI $2.84
- Average True Range (ATR)
- DOMO 0.68
- ABSI 0.20
- MACD
- DOMO 0.45
- ABSI -0.01
- Stochastic Oscillator
- DOMO 88.32
- ABSI 8.26
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.